A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC

Clinical trial NCT04856787 · TERMINATED

Trial details

NCT number: NCT04856787
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer (mCRC)

Start date: 2021-06-22
Primary completion: 2024-04-17
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.